MedTrace Logo

Upper Extremity Rehabilitation With Virtual Reality in Parkinson's Disease Patients

NCT06147726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-03-31

No results posted yet for this study

Summary

Upper extremities are the first part of the body to be affected by Parkinson's disease. Although studies have shown that virtual reality-assisted rehabilitation methods are effective on gait and balance, studies on their use for upper extremity rehabilitation are limited. For this reason, the aim of the project is to examine whether virtual reality supported upper extremity position matching exercises, which will be specially prepared according to joint ranges of motion, will provide functional improvement in the upper extremities of individuals with Parkinson's disease.

Conditions

  • Parkinson Disease
  • Virtual Reality
  • Neurological Rehabilitation
  • Upper Extremity Dysfunction

Interventions

OTHER

Upper extremity position matching exercises in virtual reality

In addition to conventional treatment approaches for 20 minutes 2 days a week for 8 weeks, joint positioning exercises (4 different game sequences of 4 minutes, 1 minute rest between each sequence, total 20 minutes) designed specifically for the individual's existing range of motion will be applied to the VR group.

OTHER

Conventional physiotherapy

proprioceptive neuromuscular facilitation techniques, parkinson-specific upper extremity and balance and gait exercises

Sponsors & Collaborators

  • Abant Izzet Baysal University

    collaborator OTHER

  • Ramazan KURUL

    lead OTHER

Principal Investigators

  • Ramazan Kurul, Ph.D · Abant Izzet Baysal University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-10-01
Completion
2024-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06147726 on ClinicalTrials.gov